Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) Short-Term Debt repayments (2016 - 2022)

Historic Short-Term Debt repayments for Prestige Consumer Healthcare (PBH) over the last 11 years, with Q3 2022 value amounting to $10.0 million.

  • Prestige Consumer Healthcare's Short-Term Debt repayments fell 8461.54% to $10.0 million in Q3 2022 from the same period last year, while for Jun 2023 it was $10.0 million, marking a year-over-year decrease of 8947.37%. This contributed to the annual value of $20.0 million for FY2023, which is 7647.06% down from last year.
  • According to the latest figures from Q3 2022, Prestige Consumer Healthcare's Short-Term Debt repayments is $10.0 million, which was down 8461.54% from $10.0 million recorded in Q2 2022.
  • Prestige Consumer Healthcare's Short-Term Debt repayments' 5-year high stood at $65.0 million during Q3 2021, with a 5-year trough of $5.0 million in Q1 2018.
  • In the last 5 years, Prestige Consumer Healthcare's Short-Term Debt repayments had a median value of $20.0 million in 2018 and averaged $26.5 million.
  • In the last 5 years, Prestige Consumer Healthcare's Short-Term Debt repayments skyrocketed by 31000.0% in 2019 and then crashed by 8461.54% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Short-Term Debt repayments (Quarter) stood at $15.0 million in 2018, then soared by 193.33% to $44.0 million in 2019, then plummeted by 65.91% to $15.0 million in 2020, then surged by 33.33% to $20.0 million in 2021, then tumbled by 50.0% to $10.0 million in 2022.
  • Its Short-Term Debt repayments was $10.0 million in Q3 2022, compared to $10.0 million in Q2 2022 and $20.0 million in Q4 2021.